Immuno-Neurology Focused Alector Files $180 Million IPO

Alector has filed for an IPO that will bring in approximately $180 million if options are exercised. The company is is focused on developing novel therapeutics that harness the brains immune system to treat neurodegenerative conditions. The company intends to trade under the symbol “ALEC”.